Publications by authors named "Jan-Peter Jansen"

Claim this Profile
C
Changes in Health-Related Quality of Life in Patients with Therapy-Resistant Migraine during Treatment with Erenumab in an Ambulatory Care Setting.
Hannah Haneke, Schirin Sulaiman, Sina Nickel, Bianca Raffaelli, Jan-Peter Jansen

J Clin Med· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of prednisone versus placebo in short-term prevention of episodic cluster headache: a multicentre, double-blind, randomised controlled trial.
Mark Obermann, Steffen Nägel, Claudia Ose, Nilüfer Sonuc, André Scherag, Jan-Peter Jansen

Lancet Neurol· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of guideline-adherent treatment in cluster headache.
Victoria Lademann, Jan-Peter Jansen, Stefan Evers, Achim Frese

Cephalalgia· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tolerability, Safety, and Quality of Life with Tapentadol Prolonged Release (PR) Compared with Oxycodone/Naloxone PR in Patients with Severe Chronic Low Back Pain with a Neuropathic Component: A Randomized, Controlled, Open-label, Phase 3b/4 Trial.
Ralf Baron, Jan-Peter Jansen, Andreas Binder, Manuel Pombo-Suarez, Lieven Kennes

Pain Pract· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New Formulation of Sustained Release Naloxone Can Reverse Opioid Induced Constipation Without Compromising the Desired Opioid Effects.
Mark Sanders, Stephen Jones, Oliver Löwenstein, Jan-Peter Jansen, Hubert Miles

Pain Med· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized, placebo-controlled trial of lubiprostone for opioid-induced constipation in chronic noncancer pain.
M Mazen Jamal, Atoya B Adams, Jan-Peter Jansen, Lynn R Webster

Am J Gastroenterol· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized, placebo-controlled phase 3 trial (Study SB-767905/012) of alvimopan for opioid-induced bowel dysfunction in patients with non-cancer pain.
Jan-Peter Jansen, Daniel Lorch, John Langan, Ben Lasko, Kai Hermanns

J Pain· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the efficacy and safety of terguride in patients with fibromyalgia syndrome: results of a twelve-week, multicenter, randomized, double-blind, placebo-controlled, parallel-group study.
Oliver Distler, Wolfgang Eich, Eva Dokoupilova, Zdenek Dvorak, Martin Fleck, Jan-Peter Jansen

Arthritis Rheum· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cistus incanus (CYSTUS052) for treating patients with infection of the upper respiratory tract. A prospective, randomised, placebo-controlled clinical study.
Ulrich Kalus, Alexandre Grigorov, Oliver Kadecki, Jan-Peter Jansen, Holger Kiesewetter

Antiviral Res· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survey to evaluate diagnosis and management of headache in primary care: Headache Management Pattern programme.
Nina De Klippel, Jan-Peter Jansen, João Sequeira Carlos

Curr Med Res Opin· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alvimopan, a peripherally acting mu-opioid receptor (PAM-OR) antagonist for the treatment of opioid-induced bowel dysfunction: results from a randomized, double-blind, placebo-controlled, dose-finding study in subjects taking opioids for chronic non-cancer pain.
Lynn Webster, Jan Peter Jansen, John Peppin, Ben Lasko, Gordon Irving

Pain· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy, tolerability and safety of oral eletriptan and ergotamine plus caffeine (Cafergot) in the acute treatment of migraine: a multicentre, randomised, double-blind, placebo-controlled comparison.
Hans-Christoph Diener, Jan-Peter Jansen, Avinoan Reches, Julio Pascual, Daniela Pitei

Eur Neurol· April 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis